| Autor: |
Iwama, Eiji, Goto, Yasushi, Murakami, Haruyasu, Harada, Taishi, Tsumura, Shinsuke, Sakashita, Hiroyuki, Mori, Yoshiaki, Nakagaki, Noriaki, Fujita, Yuka, Seike, Masahiro, Bessho, Akihiro, Ono, Manabu, Okazaki, Akihito, Akamatsu, Hiroaki, Morinaga, Ryotaro, Ushijima, Shinichiro, Shimose, Takayuki, Tokunaga, Shoji, Hamada, Akinobu, Yamamoto, Nobuyuki, Nakanishi, Yoichi, Sugio, Kenji, Okamoto, Isamu |
| Zdroj: |
Journal of Thoracic Oncology; July 2017, Vol. 12 Issue: 7 p1161-1166, 6p |
| Abstrakt: |
Alectinib has shown marked efficacy and safety in patients with anaplastic lymphoma receptor tyrosine kinase gene (ALK) rearrangement–positive NSCLC and a good performance status (PS). It has remained unclear whether alectinib might also be beneficial for such patients with a poor PS. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
